Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
Brian Bressler(University of British Columbia), Chadwick Williams, Geoffrey C. Nguyen(Johns Hopkins Medicine), Çharles N. Bernstein(University of Manitoba), Waqqas Afif, Mark Borgaonkar, John K. Marshall(McMaster University), Shane Devlin, Alain Bitton(McGill University Health Centre), Richmond Sy, Richard Fedorak, Laurent Peyrin‐Biroulet(Délégation Centre-Est), Gert Van Assche(KU Leuven), Brian G. Feagan(Western University), Grigorios I. Leontiadis(McMaster University), Laura E. Targownik(University of Manitoba), A. Hillary Steinhart(Mount Sinai Hospital), Jennifer Jones(Dalhousie University), Cynthia H. Seow(University of Calgary), Peter Thomson, Walter Reinisch(Medical University of Vienna), Francis L. S. Tse(McMaster University), Edmond-Jean Bernard(Hôtel-Dieu de Montréal), Remo Panaccione(University of Calgary)
Cited by 413
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k